Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2013 | 0.24 | Sales 2014 | 3.68 | Capitalization | 758K |
---|---|---|---|---|---|
Net income 2013 | - | Net income 2014 | -1M | EV / Sales 2013 | 8,716,069 x |
Net Debt 2013 | 1.33M | Net Debt 2014 | 1.89M | EV / Sales 2014 | 721,342 x |
P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | 191 |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
3 months | +100.00% | ||
6 months | -75.00% | ||
Current year | -92.00% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
Nikole Jessie
IRO | Public Communications Contact | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+198.00% | 7.18B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.43% | 806M | |
+1.77% | 664M | |
+6.82% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock